Grace Therapeutics, Inc. (GRCE)
Operating Cash Flow (Statement)
-$3.22M
Quarterly · Period ending: · USD
GRCE Operating Cash Flow (Statement)
Latest reported-$3.22Mperiod ending
Latest reported-$3.22Mperiod ending
GRCE Quarterly Cash from Operations (-$805.47K → -$3.22M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
GRCE operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -3,221,000 | |
| -1,706,639 | |
| -2,218,361 | |
| -3,154,639 | |
| -1,801,000 | |
| -2,954,000 | |
| -4,115,000 | |
| -4,239,000 | |
| -3,596,000 | |
| -2,088,000 | |
| -1,892,000 | |
| -2,113,000 | |
| -6,240,000 | |
| -3,326,000 | |
| -3,722,000 | |
| -3,439,000 | |
| -5,426,000 | |
| -3,145,000 | |
| -4,584,000 | |
| -6,104,000 | |
| -4,206,158 | |
| -2,210,994 | |
| -5,380,772 | |
| -5,559,264 | |
| -5,654,227 | |
| -3,563,570 | |
| -7,104,000 | |
| -6,152,000 | |
| -6,824,000 | |
| -10,073,839 | |
| -7,317,019 | |
| -5,069,620 | |
| -4,280,717 | |
| -4,457,376 | |
| -3,539,562 | |
| -1,660,580 | |
| -1,265,608 | |
| -1,341,977 | |
| -696,677 | |
| -1,588,640 | |
| -1,199,648 | |
| -1,218,556 | |
| -1,728,839 | |
| -776,070 | |
| -1,758,424 | |
| -1,946,962 | |
| -1,696,145 | |
| -461,588 | |
| -4,155,262 | |
| -814,766 | |
| -262,785 | |
| -911,201 | |
| 136,287 | |
| -581,074 | |
| -1,389,833 | |
| -631,938 | |
| -1,433,027 | |
| -3,200,067 | |
| -644,776 | |
| -425,229 | |
| -287,484 | |
| -1,245,562 | |
| -240,250 | |
| -133,598 | |
| -298,866 | |
| -591,323 | |
| -206,324 | |
| -805,471 |